Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients
Journal of the Pediatric Infectious Diseases Society · 27.12.2019 · 8 (6) · 525-530
DOI: 10.1093/jpids/piy095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 11.10.2018. Verfasst von Sara Gattis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Healthcare of Atlanta, Georgia. Hauptthemen laut MEDLINE: Influenza Vaccines, Transplant Recipients. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
In solid organ transplant (SOT) recipients, influenza infection can lead to subsequent graft dysfunction and death. Vaccination is the most effective approach to preventing influenza infection; however, vaccination rates are low, and interventions to optimize vaccine coverage are needed. The purpose of this study was to evaluate if pharmacy-initiated screening and recommendations for influenza immunization improve the rate of vaccination in pediatric SOT recipients.
Methods
We performed a retrospective pre-post chart review of all kidney, liver, and heart transplant recipients followed by Children’s Healthcare of Atlanta/Emory University transplant services between September 1, 2011, and February 16, 2017. Influenza vaccination coverage and influenza rates before (2011–2013) and after (2014–2016) the implementation of pharmacy-driven vaccination in SOT recipients were assessed.
Results
A total of 822 patients were included; 101 (13%) of these patients were diagnosed with influenza, and 40 (5%) were hospitalized secondarily during the study period. Vaccination coverage increased over time (144 [36%] patients vaccinated in 2011 vs 430 [74%] in 2016; P < .001). Influenza diagnosis rates decreased between the 2 eras (P = .006). The median time in which 50% of the population was vaccinated decreased over time from 163 days in 2012 to 94 days in 2016 (P < .001).
Conclusion
Within the constraints of the pre-post study design, we observed a significant increase in influenza vaccination rates after implementation of a transplant pharmacy-initiated screening and vaccination program. The number of patients diagnosed with influenza and the time to vaccination decreased after our pharmacy intervention. All efforts should be made to increase compliance with influenza vaccination; pharmacy-initiated interventions can improve protection against influenza infection in pediatric SOT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Children's Healthcare of Atlanta, Georgia.
- Department of Infectious Disease, Children's Healthcare of Atlanta, Georgia.
- Department of Infectious Disease, Emory University School of Medicine, Atlanta, Georgia.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Zitieren
APA
Gattis, S., Yildirim, I., Shane, A. L., Serluco, S., McCracken, C., & Liverman, R. (2019). Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society, 8(6), 525-530. https://doi.org/10.1093/jpids/piy095
Vancouver
Gattis S, Yildirim I, Shane AL, Serluco S, McCracken C, Liverman R. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society. 2019;8(6):525-530. doi:10.1093/jpids/piy095
BibTeX
@article{Gattis2019,
author = {Gattis, Sara and Yildirim, Inci and Shane, Andi L and Serluco, Staci and McCracken, Courtney and Liverman, Rochelle},
title = {Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2019},
volume = {8},
number = {6},
pages = {525--530},
doi = {10.1093/jpids/piy095}
}
EUVIMED